We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Double-bridged Peptide Tailored to Bind Tightly to Disease Targets of Interest

News   May 02, 2018 | Original story from Ecole Polytechnique Fédérale de Lausanne

 
Double-bridged Peptide Tailored to Bind Tightly to Disease Targets of Interest

A model of a double-bridged peptide (the peptide in light blue, the two bridges in yellow). The background of the figures shows many examples of skeletons (also named "scaffolds" or "backbones") of double-bridged peptides. Credit: C. Heinis/EPFL

 
 
 

RELATED ARTICLES

Why Are Some People More Receptive to Vaccination?

News

Fear, trust, and the likelihood of exposure are three leading factors that influence whether people are willing to be vaccinated against a virulent disease, according to a new study.

READ MORE

HIV Vaccine Is a Step Closer to Clinical Trials

News

A promising vaccine that clears an HIV-like virus from monkeys is a step closer to human testing after a new, weakened version of the vaccine has been shown to provide similar protection as its original version.

READ MORE

Large Study Suggests Nutrient Supplements Don’t Improve Heart Health or Put Off Death

News

In a massive new analysis of findings from 277 clinical trials using 24 different interventions, researchers say they have found that almost all vitamin, mineral and other nutrient supplements or diets cannot be linked to longer life or protection from heart disease.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE